The FDA's assessment of the bread recall has designated it as a Class II risk, which means the product "may cause temporary or medically reversible adverse health consequences." However, the classification is also used "where the probability of serious adverse health consequences is remote."

FDA Commissioner Dr. Marty Makary joins Morning Joe to address the agency’s controversial decision to keep Juul e-cigarettes on the market, ongoing reviews of mifepristone, and the latest efforts on women's health and vaccine guidance.

Taking medication for an allergic reaction? You might face severely itchy skin as a side effect of Zyrtec or Xyzal, according to a recent FDA warning for long-term users. Here's what you need to know.

The Food and Drug Administration named a longtime pharmaceutical executive to run the agency’s drug program. Dr.

The first recall affects tuna salad and ready-to-eat foods containing tuna salad sold at Jewel-Osco (which is owned by Albertsons) stores in three states: Illinois, Indiana, and Iowa. The second recall affects tuna salad and ready-to-eat foods containing tuna salad sold at three other stores in the Albertsons family,

NBC News medical contributor Dr. Natalie Azar reports on the FDA panel discussion of the use of antidepressants during pregnancy. The panel shared misinformation and facts taken out of context, according to several psychiatrists who tuned in to the meeting.

The U.S. Food and Drug Administration ( FDA) has placed an immediate clinical hold on Sarepta Therapeutics' investigational gene therapy trials for limb girdle muscular dystrophy following three patient deaths potentially linked to the company's treatments.

Dr. Peter Marks, the former director of the FDA’s Center for Biologics Evaluation and Research, urged public health leaders to take swift action to restore public trust and reaffirm the

Prefilled syringe eliminates the need to reconstitute separate vials prior to administration and simplifies the vaccine process

A Food and Drug Administration expert panel has reignited a debate over whether hormone therapy should be used to treat menopause. The 12-person panel encouraged the use of the